Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: Colonoscopy is widely recommended for colorectal cancer (CRC) screening, but evidence to guide the optimal frequency of repeat screening examination is limited. We examined the duration and magnitude of the risk of developing CRC, following a negative colonoscopy in those at average risk and those with a first-degree family history of CRC.

Methods: A cohort of Utah residents aged 50-80 years who had a negative colonoscopy between 1 January 2001 and 31 December 2011 was identified using the Utah Population Database. Patients were followed from the time of the index colonoscopy until diagnosis of CRC, death, migration out of state, repeat colonoscopy, or end of the study period. CRC incidence after the index colonoscopy was compared with that of the state population by standardized incidence ratios (SIRs).

Results: A cohort of 131,349 individuals at average risk with a negative colonoscopy was identified. Compared with the state population, a negative colonoscopy was associated with SIRs of 0.15 (95% confidence interval (CI): 0.08-0.23) at 1 year, 0.26 (95% CI: 0.19-0.32) at 2-5 years, 0.33 (95% CI: 0.22-0.43) at 5-6 years, and 0.60 (95% CI: 0.44-0.76) at 7-10 years for CRC following the index colonoscopy. In a secondary analysis involving only patients with a first-degree relative with CRC, patients had a significantly lower incidence of CRC only for the first 5 years of follow-up (SIR 0.39, 95% CI: 013-0.64). There was also a difference in the risk of proximal (SIR 0.72, 95% CI: 0.45-0.98) and distal (SIR 0.51, 95% CI: 0.30-0.72) colon cancers at 7-10 years following a negative colonoscopy.

Conclusions: The risk of developing CRC remains decreased for at least 10 years following the performance of a negative colonoscopy. However, the lower incidence of CRC in those with a family history of CRC differed in magnitude and timing being limited primarily to the first 5 years of follow-up and of lesser magnitude than that in the overall cohort.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2017.193DOI Listing

Publication Analysis

Top Keywords

negative colonoscopy
24
family history
12
colonoscopy
11
crc
10
colorectal cancer
8
risk developing
8
developing crc
8
average risk
8
years
8
years negative
8

Similar Publications

Background: The CRP-albumin-lymphocyte (CALLY) index has potential clinical value as a novel marker integrating inflammatory, nutritional and immune status in the development of colorectal polyps. This study examined whether gender factors influence the association between CALLY and colorectal polyps; in addition to elucidating whether metabolic pathways mediate this relationship.

Methods: This is a cross-sectional study including 5409 adult health screening participants who completed colonoscopy.

View Article and Find Full Text PDF

A woman in her 60s developed abdominal pain, diarrhea, and hematochezia two days after taking a single 40 mg dose of baloxavir marboxil for influenza A. Colonoscopy on day 10 revealed mucosal edema and longitudinal ulcerations confined to the sigmoid colon. A histopathological examination showed neutrophilic infiltration, crypt epithelial detachment, degeneration, and atrophy, consistent with ischemic colitis.

View Article and Find Full Text PDF

Purpose: To correlate rectal MRI findings with endoscopic margin status and depth of invasion in patients undergoing endoscopic submucosal dissection (ESD) for rectal adenomas and early rectal cancers.

Methods: Pre-treatment MRIs of patients with colonoscopy-detected polyps and early rectal cancer undergoing curative-intent ESD from 2018 to 2023 were re-interpreted by two radiologists (3- and 25-years' experience) blinded to outcomes. MRI features assessed included largest and smallest length, T2 signal intensity, degree of wall attachment, diffusion restriction and apparent diffusion coefficient values.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is an independent risk factor for perioperative respiratory complications. The STOP-Bang Questionnaire (SBQ) is a widely used screening tool; however, its utility in predicting respiratory depression during deep sedation for gastrointestinal endoscopy warrants further exploration. This study aimed to evaluate the predictive performance of the SBQ for respiratory depression in this patient population.

View Article and Find Full Text PDF

The faecal immunochemical test (FIT) is endorsed by NICE for triaging symptomatic patients referred from primary care. This prospective diagnostic accuracy study assessed the performance of FIT in detecting significant colorectal pathology among symptomatic patients referred for colonoscopy in secondary care. Between May 2023 and May 2024, FIT kits were distributed to 1296 adult patients referred for lower gastrointestinal (GI) endoscopy.

View Article and Find Full Text PDF